While some people claim dairy products can prevent cancer, others argue that dairy could actually increase the cancer risk. There are also concerns that dairy can potentially spur growth in hormone-sensitive cancers, including some forms of ovarian and breast cancer.
Is there a relationship between dairy and cancer? We consulted with the Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) Nutrition Department to find out.
Approximately 173,000 people in the United States are living with Hodgkin lymphoma, or are in remission. Less common than non-Hodgkin lymphoma, Hodgkin lymphoma (sometimes referred to as Hodgkin’s lymphoma) is a malignancy of B lymphocytes, an important cell in the immune system. This malignant B cell is known as the Reed-Sternberg cell.
Arnold Freedman, MD, clinical director of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, answers some questions about the disease:
Lymphoma: How do we treat it? Where are future therapies headed?
Ann LaCasce, MD
On Wednesday, Dec. 18, Ann LaCasce, MD, of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program will answer your questions about lymphoma care in a live video webchat. The 45-minute chat starts at 1 p.m. EST and will air live on Dana-Farber’s YouTube page.
LaCasce will discuss current treatment options as well as future therapies for lymphoma.
If you have a question for Dr. LaCasce, email email@example.com. You can also submit questions by sending us a Tweet @DanaFarber using the hashtag #DFCIWebchat.
Bookmark the webchat video page and tune in live on Dec. 18 at 1 p.m. EST. You can also add the event to your calendar or RSVP on Facebook.
Despite the research, the promising new drugs, the many ongoing clinical trials, lung cancer remains a disease that affects too many people, too often. For patients and family members, the disease carries an added burden: a stigma that lung cancer and smoking go hand in hand, and that lung cancer patients brought this on themselves. Not only must these patients and family members face their disease, but they also must carry the guilt and blame that some people cast their way.
When we posted a recent infographic on smoking and cancer, we unintentionally helped promote that stigma. We’re deeply sorry and have removed the infographic.
by Richard Saltus
As recently as five years ago, progress in treating life-threatening malignant melanoma was slow. Since then, several molecularly targeted drugs have burst on the scene, and new strategies for awakening the immune system to attack the cancer cells have yielded dramatic long-term survival benefits for some patients.
“The outlook for patients has never been so good – and we anticipate that in the next year or two it will be much better,” says Louise M. Perkins, PhD, chief science officer for the Melanoma Research Alliance, which funds research on the skin cancer.
As November marks Pancreatic Cancer Awareness Month, view the infographic below to learn more about the disease:
Current lymphoma therapies are a far cry from the mustard gas used more than 50 years ago. More treatment options, including ones that may be more effective and less toxic, are being studied in ongoing clinical trials.
“Clinical trials really are the future of lymphoma treatment,” says Ann LaCasce, MD, a medical oncologist in the Adult Lymphoma Program at Dana-Farber/Brigham and Women’s Cancer Center.
By Mark Pomerantz, MD
There has been some uncertainty surrounding this question, but recent studies have demonstrated that having a vasectomy has no effect on the risk of prostate or testicular cancer.
Older data – from studies tracking disease rates across broad population groups – suggested a modest connection, while other studies found no such link. Read more
Breast cancer is the most common cancer among American women, but only 5-10 percent of breast cancer cases are hereditary. Of those cases, roughly 20-25 percent are linked to mutations in the BRCA1 and BRCA2 genes (BRCA stands for BReast CAncer susceptibility).
View the infographic below for more on the genetics of breast cancer.